RJA
ARGX icon

Raymond James & Associates’s argenx ARGX Stock Holding History

Raymond James & Associates’s Portfolio ARGX Stock Details ARGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$29.2M Sell
53,803
-1,308
-2% -$661K 0.02% 637
2024
Q2 		$23.7M Buy
55,111
+5,633
+11% +$2.16M 0.02% 685
2024
Q1 		$19.5M Buy
49,478
+16,166
+49% +$6.26M 0.01% 790
2023
Q4 		$12.7M Sell
33,312
-459
-1% -$214K 0.01% 971
2023
Q3 		$16.6M Buy
33,771
+19,232
+132% +$9.41M 0.01% 768
2023
Q2 		$5.67M Buy
14,539
+2,343
+19% +$922K ﹤0.01% 1396
2023
Q1 		$4.54M Buy
12,196
+7,618
+166% +$2.82M ﹤0.01% 1522
2022
Q4 		$1.73M Sell
4,578
-982
-18% -$367K ﹤0.01% 2081
2022
Q3 		$1.96M Buy
5,560
+1,157
+26% +$429K ﹤0.01% 1967
2022
Q2 		$1.67M Sell
4,403
-131
-3% -$42.2K ﹤0.01% 2101
2022
Q1 		$1.43M Buy
4,534
+738
+19% +$215K ﹤0.01% 2365
2021
Q4 		$1.33M Buy
+3,796
New +$1.15M ﹤0.01% 2441

Other funds holding ARGX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Raymond James & Associates's ARGX Position: Q3 2024 in Review

Raymond James & Associates reduced its argenx (ARGX) stake by 2.4% in Q3 2024, selling an estimated $661K and leaving 53,803 shares worth $29.2M. The position accounts for 0.02% of the portfolio, ranked #637.

Raymond James & Associates first reported a position in ARGX in Q4 2021 and has held it in 12 quarters since. 357 funds tracked by Wall St. Rank hold ARGX as of Q3 2024.

  • Raymond James & Associates held 53,803 shares of argenx worth $29.2M as of Q3 2024.
  • Raymond James & Associates sold 1,308 argenx shares in Q3 2024, an estimated $661K.
  • argenx made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #637 holding.
  • Raymond James & Associates first reported a position in argenx in Q4 2021 and has held it in 12 quarters since.
  • 357 funds tracked by Wall St. Rank held argenx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.